$13.93+77.00% · 3M
Moving avg
1W+4.27%
1M+31.91%
3M+77.00%
6M+44.50%
YTD+21.55%
1Y+10.03%
3Y-34.04%
5Y-63.86%
52-week range
$7.2777% of range$15.93
Company health
Value3/6
Growth6/6
Profitability1/6
Health3/6
Dividend0/6
Bull vs bear
Strengths
- Revenue compounding 26% a year
Risks
- Trades 35% above the average analyst target
- Currently unprofitable
Key statistics
Valuation
Market cap
$9.42B
Enterprise value
$10.82B
P/E ratio (TTM)
-13.26x
P/S ratio (TTM)
1.11x
EV/EBITDA
85.23x
Per share & returns
EPS (TTM)
-$0.81
Dividend yield
0.00%
Beta (1Y)
0.94
30-day change
+31.91%
Trading
Volume (24h)
4.74M
Previous close
$13.77
Shares outstanding
676.36M
About Avantor, Inc.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NYSE
Symbol
AVTR
Avantor, Inc. is a mid-cap healthcare company in the Medical - Instruments & Supplies industry. Its shares are listed on NYSE (United States) and trade under the ticker AVTR.
Frequently asked questions
What is Avantor, Inc.'s market cap?
Avantor, Inc. (AVTR) has a market capitalization of $9.42B.
What sector is Avantor, Inc. in?
Avantor, Inc. operates in the Healthcare sector, Medical - Instruments & Supplies industry.
What exchange does AVTR trade on?
AVTR trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.10-0.11%
$357.06B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.92-0.23%
$289.38B cap
AstraZeneca PLCLON: AZN
£116.38-0.55%
$243.29B cap